The New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) funding from the National Institutes of Health (NIH) seeks to encourage multidisciplinary investigators to develop exploratory, highly novel new approaches, or innovative applications of existing approaches, to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment.
The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages. Applications are open to researchers in the USA and worldwide.
The award provides up to 275,000 USD for up to 2 years (plus indirect costs).
Funding opportunity number: PA-25-272
Applications are due on February, June and October 16 with the final deadline on February 16, 2027.